Using impedancemetry to monitor hydration and sodium levels in patients with subarachnoid hemorrhage

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients who have experienced a subarachnoid hemorrhage (SAH), a serious type of stroke. It aims to evaluate the effectiveness of impedancemetry, a technique that measures water volumes and sodium levels, in managing hydration and preventing complications like delayed cerebral ischemia. By monitoring these parameters, the study seeks to improve patient outcomes in the neurological intensive care unit. Participants will be adults hospitalized within 72 hours of their SAH diagnosis and will be monitored for their hydration status and sodium balance.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult man, woman
* Hospitalized following Subarachnoid Hemorrhage within 72 hours of bleeding
* Admitted to the neurological intensive care unit for less than 48 hours
* Being able to understand the ins and outs of the study
* Having expressed his non-opposition

Exclusion Criteria:

* Patients under legal protection
* Pregnancy

Where it's running

• Hospices Civils de Lyon. Neurological ICU
  Lyon, France, France Recruiting

Study contacts

• Study coordinator: Thomas RITZENTHALER, MD
• Email: Thomas.ritzenthaler@chu-lyon.fr
• Phone: 04.72.11.66.02

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Daily IV dornase alfa after a ruptured brain aneurysm to improve independence at six months.

  This test will try daily intravenous dornase alfa in people with aneurysmal subarachnoid hemorrhage to see if it helps them be more functionally independent at six months.

  Recruiting at 6 sites Phase 2 Fondation Ophtalmologique Adolphe de Rothschild · Grenoble, Grenoble and 5 other locations · NCT06723717

• Transnasal nerve block for headaches after brain hemorrhage

  This study is testing if a special nose treatment can help reduce headaches in people who have had a brain hemorrhage and see if it can lower their need for pain medication.

  Recruiting Phase 2/3 University of California, Davis · Sacramento, California · NCT06621329

• Understanding cerebral vasospasm in traumatic brain injury with subarachnoid hemorrhage

  This study is testing how common and serious blood vessel narrowing in the brain is for adults with moderate to severe traumatic brain injuries and bleeding, to see if better scans can help improve their care.

  Recruiting University Hospital Center of Martinique · Fort-de-France · NCT06560372

• Intra-arterial lidocaine and methylprednisolone for SAH-related headaches

  This study tests whether injecting lidocaine and methylprednisolone into the middle meningeal artery can lessen headaches after a subarachnoid hemorrhage in adults undergoing routine brain imaging.

  Recruiting Phase 2 University of California, San Francisco · San Francisco, California · NCT07054801

• AI-based EEG for better stroke and post-cardiac arrest outcomes

  Researchers are testing whether a simple subhairline EEG patch plus AI can help predict outcomes after cardiac arrest and detect brain bleeds in stroke patients.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam, North Holland · NCT07886957

• Metabolomics biomarkers to predict outcomes after subarachnoid hemorrhage

  This study tests whether blood and CSF biomarkers, together with clinical data, can predict recovery a year after spontaneous subarachnoid hemorrhage in adults treated in Lisbon.

  Recruiting Unidade Local de Saude Sao Jose · Lisbon, Lisbon District · NCT07865182

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.